SLC38A5 and breast carcinoma: The up-regulation of SLC38A5 was evident in breast cancer samples as well as cell lines, and silencing of SLC38A5 attenuated cell proliferation in TNBC cells accompanied by reduced micropinocytosis, suggesting the oncogenic role of SLC38A5 in TNBC (Ramachandran et al., 2021).